Michael Weller, MD
Enriched profileAssociate Staff in the Department of Radiation Oncology at Hillcrest Hospital · Hillcrest Hospital (Cleveland Clinic)
Michael Weller is Associate Staff in the Department of Radiation Oncology at Hillcrest Hospital at Hillcrest Hospital (Cleveland Clinic). ClinicalTrials.gov lists 14 registered studies with this person as an investigator.
Data verified 9 Nov 2026
Overview
Updated 17 Nov 2026
Michael Weller, M.D., is Associate Staff in the Department of Radiation Oncology at Hillcrest Hospital. It also documents an investigator role on 14 registered clinical trials.
- Top research focus: Neuro-Oncology / Glioma
- 14 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 9 Nov 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Sponsor: ETOP IBCSG Partners Foundation
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
100%alpha-Adrenergic Blocker100%Tamsulosin Hcl100%Part D≥19 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 9 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Mitchel Berger, MD
University of California, San Francisco (UCSF)
Patrick Wen, MD
Dana-Farber Cancer Institute
Kenneth Aldape, MD
Mayo Clinic
Michael Prados, MD
UCSF